Current insights into inositol isoforms, mediterranean and ketogenic diets for polycystic ovary syndrome: From bench to bedside

Giovanna Muscogiuri, Stefano Palomba, Antonio Simone Laganà, Francesco Orio

Research output: Contribution to journalReview article

  • 2 Citations

Abstract

Background: Polycystic ovary syndrome (PCOS) is a complex syndrome characterized by reproductive and metabolic implications. Lifestyle changes, such as diet and exercise, are considered first-line treatment for women affected by PCOS. Pharmacologic treatments target the hormonal and metabolic dysregulations associated to the disease such as insulin resistance, anovulation, hirsutism and menstrual irregularities. Objective: To focus on the role of inositol isoforms, as well as Mediterranean and ketogenic diets, as possible therapeutic strategies in PCOS women. Method: Narrative overview, synthesizing the findings of literature retrieved from searches of computerized databases. Results: Accumulating evidence suggests that two inositol isoforms, myo-and D-chiro-, may play a pivotal role in re-addressing both hormonal and metabolic parameters toward homeostasis, counteracting the symptoms and signs typical of this syndrome. In addition, studies focused on Mediterranean and ketogenic diet provided positive results in patients affected by obesity and type 2 diabetes, so these dietetic regimens could represent a fascinating dietetic treatment for the management of PCOS Conclusion: Both the isoforms of inositol are effective in improving ovarian function and metabolism in patients with PCOS. In spite of accumulating evidence, it is currently not possible to draw firm conclusion (s) about the efficacy of these interventions considering the severe bias due to different samples size, dose, and duration of intervention among the published studies on this topic. Furthermore, future longitudinal cohort studies along with prospective interventional trials may contribute to better clarify the role of Mediterranean and ketogenic diets in the treatment of PCOS.

Original languageEnglish
Pages (from-to)5554-5557
Number of pages4
JournalCurrent Pharmaceutical Design
Volume22
Issue number36
DOIs
StatePublished - Oct 1 2016

Fingerprint

Ketogenic Diet
Mediterranean Diet
Polycystic Ovary Syndrome
Inositol
Protein Isoforms
Dietetics
Anovulation
Hirsutism
Longitudinal Studies
Insulin Resistance
Life Style
Homeostasis
Cohort Studies
Obesity
Exercise
Diet

Keywords

  • D-chiroinositol
  • Ketogenic diet
  • Mediterranean diet
  • Myo-inositol
  • Outcomes
  • Polycystic ovary syndrome

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Current insights into inositol isoforms, mediterranean and ketogenic diets for polycystic ovary syndrome : From bench to bedside. / Muscogiuri, Giovanna; Palomba, Stefano; Laganà, Antonio Simone; Orio, Francesco.

In: Current Pharmaceutical Design, Vol. 22, No. 36, 01.10.2016, p. 5554-5557.

Research output: Contribution to journalReview article

Muscogiuri, Giovanna; Palomba, Stefano; Laganà, Antonio Simone; Orio, Francesco / Current insights into inositol isoforms, mediterranean and ketogenic diets for polycystic ovary syndrome : From bench to bedside.

In: Current Pharmaceutical Design, Vol. 22, No. 36, 01.10.2016, p. 5554-5557.

Research output: Contribution to journalReview article

@article{c19ddf581bfc4c4a8a9be8a32ad87d26,
title = "Current insights into inositol isoforms, mediterranean and ketogenic diets for polycystic ovary syndrome: From bench to bedside",
abstract = "Background: Polycystic ovary syndrome (PCOS) is a complex syndrome characterized by reproductive and metabolic implications. Lifestyle changes, such as diet and exercise, are considered first-line treatment for women affected by PCOS. Pharmacologic treatments target the hormonal and metabolic dysregulations associated to the disease such as insulin resistance, anovulation, hirsutism and menstrual irregularities. Objective: To focus on the role of inositol isoforms, as well as Mediterranean and ketogenic diets, as possible therapeutic strategies in PCOS women. Method: Narrative overview, synthesizing the findings of literature retrieved from searches of computerized databases. Results: Accumulating evidence suggests that two inositol isoforms, myo-and D-chiro-, may play a pivotal role in re-addressing both hormonal and metabolic parameters toward homeostasis, counteracting the symptoms and signs typical of this syndrome. In addition, studies focused on Mediterranean and ketogenic diet provided positive results in patients affected by obesity and type 2 diabetes, so these dietetic regimens could represent a fascinating dietetic treatment for the management of PCOS Conclusion: Both the isoforms of inositol are effective in improving ovarian function and metabolism in patients with PCOS. In spite of accumulating evidence, it is currently not possible to draw firm conclusion (s) about the efficacy of these interventions considering the severe bias due to different samples size, dose, and duration of intervention among the published studies on this topic. Furthermore, future longitudinal cohort studies along with prospective interventional trials may contribute to better clarify the role of Mediterranean and ketogenic diets in the treatment of PCOS.",
keywords = "D-chiroinositol, Ketogenic diet, Mediterranean diet, Myo-inositol, Outcomes, Polycystic ovary syndrome",
author = "Giovanna Muscogiuri and Stefano Palomba and Laganà, {Antonio Simone} and Francesco Orio",
year = "2016",
month = "10",
doi = "10.2174/1381612822666160720160634",
volume = "22",
pages = "5554--5557",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "36",

}

TY - JOUR

T1 - Current insights into inositol isoforms, mediterranean and ketogenic diets for polycystic ovary syndrome

T2 - Current Pharmaceutical Design

AU - Muscogiuri,Giovanna

AU - Palomba,Stefano

AU - Laganà,Antonio Simone

AU - Orio,Francesco

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background: Polycystic ovary syndrome (PCOS) is a complex syndrome characterized by reproductive and metabolic implications. Lifestyle changes, such as diet and exercise, are considered first-line treatment for women affected by PCOS. Pharmacologic treatments target the hormonal and metabolic dysregulations associated to the disease such as insulin resistance, anovulation, hirsutism and menstrual irregularities. Objective: To focus on the role of inositol isoforms, as well as Mediterranean and ketogenic diets, as possible therapeutic strategies in PCOS women. Method: Narrative overview, synthesizing the findings of literature retrieved from searches of computerized databases. Results: Accumulating evidence suggests that two inositol isoforms, myo-and D-chiro-, may play a pivotal role in re-addressing both hormonal and metabolic parameters toward homeostasis, counteracting the symptoms and signs typical of this syndrome. In addition, studies focused on Mediterranean and ketogenic diet provided positive results in patients affected by obesity and type 2 diabetes, so these dietetic regimens could represent a fascinating dietetic treatment for the management of PCOS Conclusion: Both the isoforms of inositol are effective in improving ovarian function and metabolism in patients with PCOS. In spite of accumulating evidence, it is currently not possible to draw firm conclusion (s) about the efficacy of these interventions considering the severe bias due to different samples size, dose, and duration of intervention among the published studies on this topic. Furthermore, future longitudinal cohort studies along with prospective interventional trials may contribute to better clarify the role of Mediterranean and ketogenic diets in the treatment of PCOS.

AB - Background: Polycystic ovary syndrome (PCOS) is a complex syndrome characterized by reproductive and metabolic implications. Lifestyle changes, such as diet and exercise, are considered first-line treatment for women affected by PCOS. Pharmacologic treatments target the hormonal and metabolic dysregulations associated to the disease such as insulin resistance, anovulation, hirsutism and menstrual irregularities. Objective: To focus on the role of inositol isoforms, as well as Mediterranean and ketogenic diets, as possible therapeutic strategies in PCOS women. Method: Narrative overview, synthesizing the findings of literature retrieved from searches of computerized databases. Results: Accumulating evidence suggests that two inositol isoforms, myo-and D-chiro-, may play a pivotal role in re-addressing both hormonal and metabolic parameters toward homeostasis, counteracting the symptoms and signs typical of this syndrome. In addition, studies focused on Mediterranean and ketogenic diet provided positive results in patients affected by obesity and type 2 diabetes, so these dietetic regimens could represent a fascinating dietetic treatment for the management of PCOS Conclusion: Both the isoforms of inositol are effective in improving ovarian function and metabolism in patients with PCOS. In spite of accumulating evidence, it is currently not possible to draw firm conclusion (s) about the efficacy of these interventions considering the severe bias due to different samples size, dose, and duration of intervention among the published studies on this topic. Furthermore, future longitudinal cohort studies along with prospective interventional trials may contribute to better clarify the role of Mediterranean and ketogenic diets in the treatment of PCOS.

KW - D-chiroinositol

KW - Ketogenic diet

KW - Mediterranean diet

KW - Myo-inositol

KW - Outcomes

KW - Polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=84995877349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995877349&partnerID=8YFLogxK

U2 - 10.2174/1381612822666160720160634

DO - 10.2174/1381612822666160720160634

M3 - Review article

VL - 22

SP - 5554

EP - 5557

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 36

ER -